4//SEC Filing
Leong Justin 4
Accession 0001127602-22-026349
CIK 0000943819other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 4:42 PM ET
Size
9.7 KB
Accession
0001127602-22-026349
Insider Transaction Report
Form 4
RESMED INCRMD
Leong Justin
Chief Product Officer
Transactions
- Exercise/Conversion
ResMed Common Stock Options
2022-11-22−15,000→ 0 totalExercise: $57.76From: 2017-11-16Exp: 2023-11-16→ ResMed Common Stock (15,000 underlying) - Exercise/Conversion
ReMed Common Stock
2022-11-22$57.76/sh+15,000$866,400→ 63,594 total - Sale
ReMed Common Stock
2022-11-22$229.50/sh−3,777$866,820→ 59,817 total - Award
ReMed Common Stock
2022-11-23+6,924→ 66,741 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $229.42 $229.56. The price reported above reflects the weighted average sale price.
- [F2]Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on November 23, 2022, when the compensation committee certified that the performance metrics were met.
Documents
Issuer
RESMED INC
CIK 0000943819
Entity typeother
Related Parties
1- filerCIK 0001825782
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 4:42 PM ET
- Size
- 9.7 KB